Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Calcium signaling pathway | R-HSA-381753 | map04020 | alvespimycin | 43815 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | alvespimycin | 43815 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | alvespimycin | 43815 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | alvespimycin | 43815 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | probenecid | 104981 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | probenecid | 104981 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | probenecid | 104981 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | probenecid | 104981 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | probenecid | 104981 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | probenecid | 104981 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | probenecid | 104981 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | probenecid | 104981 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | probenecid | 104981 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | probenecid | 104981 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | selegiline | 26757 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | selegiline | 26757 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | selegiline | 26757 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | selegiline | 26757 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | selegiline | 26757 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 6-azathymine | 70269 | drug-path |